|
Match
|
Document |
Document Title |
|
|
7238375 |
Composition and method to promote human hair growth
This invention relates to a composition of matter for producing hair growth and preventing hair loss in humans and the method for using said composition. The composition comprises four complexes...
|
|
|
6924299 |
Methods and compositions useful in enhancing oxygen delivery to cells
The invention discloses compositions and methods which are useful in improving delivery of oxygen to cells. The compositions require at least one derivative of a compound. The derivatives are...
|
|
|
5612382 |
Composition for percutaneous absorption of pharmaceutically active ingredients
A pharmaceutical composition for transdermally delivering pharmaceutically active ingredients through skin or mucosal tissues. The composition comprises pharmaceutically active ingredients in...
|
|
|
5256678 |
Normal-pentadecyl nicotinate N-oxide and hair restorer comprising the same
This invention relates to n-pentadecyl nicotinate N-oxide, a hair restorer composition comprising said compound as the active ingredient and a method of hair restoring utilizing said compound.
|
|
|
5157036 |
Composition for inducing and stimulating hair growth and retarding its loss, based on nicotinic esters and pyrimidine derivatives
The subject of the invention is a new composition comprising a nicotinic ester with a pyrimidine derivative, to produce hair regrowth much more rapidly than with the pyrimidine derivative alone,...
|
|
|
5025026 |
Hair restorer
This invention relates to a hair restorer comprising n-pentadecyl nicotinate as an active ingredient and has an outstandingly potent hair restorative action. The hair restorer of this invention is...
|
|
|
4968685 |
Composition for inducing and stimulating hair growth and retarding its loss, based on nicotinic esters and pyrimidine derivatives
The invention relates to a composition for inducing and stimulating hair growth and retarding its loss, containing, in a cosmetically or pharmaceutically acceptable medium, at least one pyrimidine...
|
|
|
4847260 |
Composition for percutaneous administration
A composition for percutaneous administration containing a nicotinic ester represented by formula (I) ##STR1## or an isonicotinic ester represented by formula (II) ##STR2## wherein R and R' each...
|
|
|
EP0220825A2 |
Pharmaceutical composition for topical application.
Compositions for topical application useful for preventing pressure sores comprise a slow-acting nicotinate ester, e.g. hexyl nicotinate, in a concentration and formulation insufficient to cause...
|
|
|
EP0182635A1 |
Composition for percutaneous administration.
Abstract not available for EP0182635 Abstract of corresponding document: US4847260 A composition for percutaneous administration containing a nicotinic ester represented by formula (I) (I) or an...
|
|
|
4404212 |
Prostacyclin treatment of thrombosis
Pharmaceutical combinations comprising (a) prostacyclin, dihydroprostacyclin or a pharmaceutically acceptable salt of either of these, and (b) a phosphodiesterase inhibitor. Pharmaceutical...
|
|
|
4393063 |
Treatment for gastric lesions
Pharmaceutical combinations comprising (a) prostacyclin, dihydroprostacyclin or a pharmaceutically acceptable salt of either of these, and (b) a phosphodiesterase inhibitor. Pharmaceutical...
|
|
|
4337254 |
Pharmaceutical compositions
Pharmaceutical combinations comprising (a) prostacyclin, dihydroprostacyclin or a pharmaceutically acceptable salt of either of these, and (b) a phosphodiesterase inhibitor. Pharmaceutical...
|
|
|
EP0008227A1 |
Pharmaceutical compositions for topical administration containing prostaglandins.
Abstract not available for EP0008227 Abstract of corresponding document: US4254145 Pharmaceutical compositions useful as vasodilators whose activity may be restricted to the site of application by...
|
|
|
2744851 |
Cardiac glycosides for intramuscular injection
|
|
|
2524838 |
Esters of pyridyl-3-carbinol
|